DOI QR코드

DOI QR Code

임상검체로부터 분리한 플라스미드 매개성 SHV-11 β-lactamase 유전자의 특성

Characterization of Plasmid-Mediated SHV-11 β-lactamase Gene of Klebsiella pneumoniae Isolated from the Clinical Specimens

  • Kim, Yun-Tae (Department of Microbiology Genetics, Seoul Medical Science Institute/Seoul Clinical Laboratories) ;
  • Lee, Sang-Hoo (Department of Microbiology Genetics, Seoul Medical Science Institute/Seoul Clinical Laboratories) ;
  • Jang, Ji-Hyun (Department of Microbiology Genetics, Seoul Medical Science Institute/Seoul Clinical Laboratories) ;
  • Kim, Tae-Un (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Choi, Seok-Cheol (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Baik, Hyung-Suk (Division of Biological Science, Pusan National University) ;
  • Lee, Kyoung-Ryul (Department of Microbiology Genetics, Seoul Medical Science Institute/Seoul Clinical Laboratories) ;
  • Yoon, Hye-Ryoung (Department of Microbiology Genetics, Seoul Medical Science Institute/Seoul Clinical Laboratories) ;
  • Kim, Young-Jin (Department of Microbiology Genetics, Seoul Medical Science Institute/Seoul Clinical Laboratories)
  • 발행 : 2009.12.30

초록

Chromosomal 인 SHV-11 $\beta$-lactamase가 plasmid를 매개로 다른 균주로 전달 되는 현상은 흔하지 않다. 본 연구에서는 플라스미드성 SHV-11 $\beta$-lactamase를 동시에 가지고 있는 ESBL생성 두 균주를 검출하였다. 따라서 이들 균주에 대한 유전적 특성과 임상적 의의에 대해 알아보고자 하였다. Vitek system과 이중디스크확산법을 이용하여 ESBL생성균주를 검출하였고, PCR과 DNA 염기서열분석을 이용하여 SHV-11 $\beta$-lactamase를 가지고 있는 ESBL생성균주를 확인 하였다. 이들 균주를 교차접합실험과 형질전환실험을 이용하여 유전자전이를 확인하고 액체배지 희석법으로 3세대 cephalosphorin 항생제에 대한 최소억제농도를 측정하였다. 이들 균주의 유전형 분석결과는 SHV-11 $\beta$-lactamase 유전자와 CTX-M-15 ESBL 유전자를 동시에 가지고 있었다. 3세대 cephalosphorin 항생제에 대한 최소억제농도는 SHV-11 $\beta$-lactamase와 CTX-M-15 ESBL 유전자를 동시에 가지고 있는 균주에서 $64{\mu}g/ml$ 이상이었고, SHV-11 $\beta$-lactamase 만을 가지고 재조합 한 균주에서 $0.5{\mu}g/ml$ 이하로 나타났다.

In this study, we characterized extended-spectrum $\beta$-lactamase (ESBL)-producing Enterobacteriaceae isolated from clinical specimens in Korea and found two strains harboring plasmid-mediated $bla_{SHV-11}$, Klebsiella pneumoniae. First, the isolates were detected using the Vitek system and confirmed by the double-disk synergy test. The classification of gene coding for ESBL was also performed by polymerase chain reactions and followed by DNA sequencing. The transmission of genes was confirmed by transconjugation and transformation. Resistant expression of transformants was determined by broth microdilution minimal inhibitory concentration test. Genotypic analysis revealed that one strain harbored the $bla_{TEM-1}$, $bla_{SHV-11}$ and $bla_{CTX-M-15}$ and the other strain harbored the $bla_{SHV-11}$ and $bla_{CTX-M-15}$. They showed high resistance to oxyiminocephalosphorins (3rd-generation cephalosporins), while the transformant containing only $bla_{SHV-11}$ did not show any resistance to the antibiotics.

키워드

참고문헌

  1. Ahamed, J. and K. Manikuntala. 1999. Molecular characterization of the SHV-ll $\beta$-Lactamase of Shigella dysenteriae. J. Antimicrob. Chemother. 43, 2081 - 2083
  2. Arlet, G. M., M. Rouveau, I. Casin, J. M. Bouveau, P. H. Lagrange, and A. Philipp on. 1994. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 $\beta$-lactamase and which were isolated in 14 French hospitals. J. Clin. Microbiol. 32, 2553-2558
  3. Bradford, P. A. 2001. Extended-spectrum $\beta$-lactamase in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14, 933-951 https://doi.org/10.1128/CMR.14.4.933-951.2001
  4. Bush, K. and G. Jacoby. 1997. Nomenclature of TEM $\beta$- lactamases. J. Antimicrob. Chemother. 39, 1-3
  5. Chanawong, A, F. H M'Zali, J. Heritage, J. H Xiong, and P. M. Hawkey. 2002. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob. Agents. Chemother. 46, 630-637 https://doi.org/10.1128/AAC.46.3.630-637.2002
  6. Datta, N. and P. Kontomichalou. 1965. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature 208, 239-244 https://doi.org/10.1038/208239a0
  7. David, L. P. and R. A Bonomo. 2005. Extended-spectrum $\beta$-lactamase: a clinical update. Clin. Microbiol. Rev. 18, 657-686 https://doi.org/10.1128/CMR.18.4.657-686.2005
  8. Forbes, B. A, D. F. Sahm, and A S. Weissfeld. 2002. Enterobacteriaceae in Baily & scott's Diagnostic Microbiology, pp. 365-375. 11th eds. Mosby, Inc., St. Louis
  9. Gallego, L., A Umaran, J. Garaizar, K Colom, and R. Cisterna. 1990. Digoxigenin-Iabeled DNA probe to detect TEM type $\beta$-lactamases. J. Microbiol. Methods 11, 261-267 https://doi.org/10.1016/0167-7012(90)90063-C
  10. Hong, S. G, J. Lee, D. Yong, E. C. Kim, S. H Jeong, and Y. J. Park. 2004. Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea. Korean J. Clin. Microbiol. 7, 171-177
  11. Kim, Y. T. and T. U. Kim. 2006. Prevalence of CTX-M-type Extended-Spectrum $\beta$-Lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in general hospitals in 2005. Korean J. Microbiol. Biotechnol. 36, 342-351
  12. Kim, Y. T., T. U. Kim, and H S. Baik. 2006. Characterization of Extended Spectrum $\beta$-Lactamase genotype TEM, SHY and CTX-M producing Klebsiella pneumoniae isolated from Clinical specimen in Korea. J. Microbiol. Biotechnol. 16, 889-895
  13. Kim, Y. T. 2007. Analysis of antibiotic resistant patterns in conjugant and transformant of three ESBL gene harboring Klebsiella pneumoniae. J. Life. Sci. 17, 1426-1433
  14. Kim, Y. T. and H K Lee. 2000. Extended-Spectrum $\beta$Lactamase (ESBL) typing of Klebsiella pneumoniae isolated from clinical specimen in Pusan. Korean J. Microbiol. 36, 221-227
  15. Lee, Y. H, B. K Cho, I. K Bae, C. L. Chang, and S. H. Jeong. 2006. Klebsiella pneumoniae strains carrying the chromosomal SHY -11 $\beta$-lactamase gene produce the plasmid-mediated SHV-12 extended-spectrum $\beta$-lactamase more frequently than those carrying the chromosomal SHV-1 $\beta$-lactamase gene. Antimicrob. Agents. Chemother. 57, 1259-1261 https://doi.org/10.1093/jac/dkl115
  16. Lee, S. H, J. Y. Kim, S. H Shin, Y. J. An, Y. W. Choi, and Y. C. Jung. 2003. Dissemination of SHV-12 and characterization of New AmpC-type $\beta$-lactamase genes among clinical isolates of Enterobacter species in Korea. J. Clin. Microbiol. 41, 2477-2482 https://doi.org/10.1128/JCM.41.6.2477-2482.2003
  17. Moland, E. S., J. A Black, A Hossain, N. D. Hanson, K S. Thomson, and S. Pottumarthy. 2003. Discovery of CTXM-like extended-spectrum $\beta$-lactamases in Escherichia coli isolates from five U.s. states. Antimicrob. Agents. Chemother. 47, 2382-2383 https://doi.org/10.1128/AAC.47.7.2382-2383.2003
  18. NCCLS. 2004. Performance Standards for Antimicrobial Susceptibility Testing: 5th Informational Supplement. pp. M100-SS. 5th Ed. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania
  19. Nordmann, P. 1998. Trends in $\beta$-lactam resistance among Enterobacteriaceae. Clin. Infect. Dis. 27, S100-106 https://doi.org/10.1086/514905
  20. Nuesch-Inderbinen, M. T., F. H. Kayser, and H. Hachler. 1997. Survey and molecular genetics of SHY $\beta$-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob. Agents. Chemother. 41, 943-949
  21. Poiret L., M. Gniadkowski, and P. Nordmann. 2002. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum $\beta$-lactamase CTX-M-15 and of its structurally related $\beta$-lactamase, CTX-M-3. J. Antimicrob. Chemother. 50, 1031-1034 https://doi.org/10.1093/jac/dkf240
  22. Stobberingh, E. E., J. Arends, J. A Hoogkamp-Korstanje, W. H Goessens, M. R. Visser, and A G Buiting. 1999. Occurrence of extended-spectrum $\beta$-lactamases (ESBL) in Dutch hospitals. Infect. 27, 348-354 https://doi.org/10.1007/s150100050041
  23. Twum-Danso, K., C. Grant, S. A. AI-Suleiman, S. Abdel-Khader, M. S. AI- Awami, H. AI-Breiki, and S. Taha. 1992. Microbiology of postoperative wound infection: a prospective study of 1770 wounds. J. Hosp. Infect. 21, 29-37 https://doi.org/10.1016/0195-6701(92)90151-B
  24. Tzouvelekis, L. S. and R. A Bonomo. 1999. SHY-type $\beta$lactamases. Curro Pharm. Des. 5, 847-864
  25. Winokur, P. L., R. Canton, J. M. Casellas, and N. Legakis. 2001. Variations in the prevalence of strains expressing an extended-spectrum $\beta$-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacificregion. Clin. Infect. Dis. 32 (Suppl. 2), S94-103 https://doi.org/10.1086/320182